Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Overview of the Use of Murine Models in Leukemia and Lymphoma Research
Rebecca Kohnken, Pierluigi Porcu, Anjali Mishra
Frontiers in Oncology (2017) Vol. 7
Open Access | Times Cited: 88

Showing 1-25 of 88 citing articles:

MYC: a multipurpose oncogene with prognostic and therapeutic implications in blood malignancies
Seyed Esmaeil Ahmadi, Samira Rahimi, Bahman Zarandi, et al.
Journal of Hematology & Oncology (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 138
Chemokine-Directed Tumor Microenvironment Modulation in Cancer Immunotherapy
Pedro Bule, Sandra I. Aguiar, Frederico Aires‐da‐Silva, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 18, pp. 9804-9804
Open Access | Times Cited: 133
The paradoxical role of cytokines and chemokines at the tumor microenvironment: a comprehensive review
Toufik Abdul‐Rahman, Shankhaneel Ghosh, Sarah M. Badar, et al.
European journal of medical research (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 26
Orthotopic and metastatic tumour models in preclinical cancer research
Stephen M. Stribbling, Callum Beach, Anderson J. Ryan
Pharmacology & Therapeutics (2024) Vol. 257, pp. 108631-108631
Open Access | Times Cited: 17
Targeting ferroptosis for leukemia therapy: exploring novel strategies from its mechanisms and role in leukemia based on nanotechnology
Muhammad Hossein Ashoub, Razieh Razavi, Kamran Heydaryan, et al.
European journal of medical research (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 16
Design and optimisation of dendrimer-conjugated Bcl-2/xL inhibitor, AZD0466, with improved therapeutic index for cancer therapy
Claire Patterson, Srividya B. Balachander, Iain Grant, et al.
Communications Biology (2021) Vol. 4, Iss. 1
Open Access | Times Cited: 76
Exploring Anticancer, Antioxidant, and Antimicrobial Potential of Aspergillus flavus, a Fungal Endophyte Isolated from Dillenia indica Leaf Callus
Ashish Kumar Gupta, Brajesh Chandra Pandey, Mohd Yaseen, et al.
Heliyon (2025), pp. e42142-e42142
Open Access | Times Cited: 1
Nanoparticles—Emerging Potential for Managing Leukemia and Lymphoma
Raquel Vinhas, Rita Mendes, Alexandra R. Fernandes, et al.
Frontiers in Bioengineering and Biotechnology (2017) Vol. 5
Open Access | Times Cited: 73
Epigenetic activation of a RAS/MYC axis in H3.3K27M-driven cancer
Sanja Pajovic, Robert Siddaway, Taylor Bridge, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 53
Chronic myeloid leukemia stem cells: targeting therapeutic implications
Hanieh Mojtahedi, Niloufar Yazdanpanah, Nima Rezaei
Stem Cell Research & Therapy (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 50
Spleen cancer: Current status of preclinical research
Gaurav Tiwari, Surender Beniwal, Shashi Ravi Suman Rudrangi, et al.
Elsevier eBooks (2025), pp. 45-68
Closed Access
Modelling acute myeloid leukemia (AML): What’s new? A transition from the classical to the modern
Annachiara Dozzo, Aoife Galvin, Jae‐Won Shin, et al.
Drug Delivery and Translational Research (2022) Vol. 13, Iss. 8, pp. 2110-2141
Open Access | Times Cited: 22
DNase 1 Protects From Increased Thrombin Generation and Venous Thrombosis During Aging: Cross‐Sectional Study in Mice and Humans
Rahul Kumar, Vijay K. Sonkar, Jagadish Swamy, et al.
Journal of the American Heart Association (2022) Vol. 11, Iss. 2
Open Access | Times Cited: 19
Three-Dimensional Human Bone Marrow Organoids for the Study and Application of Normal and Abnormal Hematoimmunopoiesis
Alejandro de Janon, Athanasios Mantalaris, Nicki Panoskaltsis
The Journal of Immunology (2023) Vol. 210, Iss. 7, pp. 895-904
Open Access | Times Cited: 12
Leukemia’s Next Top Model? Syngeneic Models to Advance Adoptive Cellular Therapy
Jaquelyn T. Zoine, Sarah E. Moore, Mireya Paulina Velasquez
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 16
Preclinical Evidence for Targeting PI3K/mTOR Signaling with Dual-Inhibitors as a Therapeutic Strategy against Cutaneous T-Cell Lymphoma
Antonella Bresin, Cristina Cristofoletti, Elisabetta Caprini, et al.
Journal of Investigative Dermatology (2019) Vol. 140, Iss. 5, pp. 1045-1053.e6
Open Access | Times Cited: 27
Driver mutations in Janus kinases in a mouse model of B-cell leukemia induced by deletion of PU.1 and Spi-B
Carolina R. Batista, Michelle Gek Liang Lim, Anne-Sophie Laramée, et al.
Blood Advances (2018) Vol. 2, Iss. 21, pp. 2798-2810
Open Access | Times Cited: 27
Tissue engineered models of healthy and malignant human bone marrow
Alan Chramiec, Gordana Vunjak‐Novakovic
Advanced Drug Delivery Reviews (2019) Vol. 140, pp. 78-92
Open Access | Times Cited: 24
Rapid generation of CD19 CAR-T cells by minicircle DNA enables anti-tumor activity and prevents fatal CAR-B leukemia
Xueshuai Ye, Yongqiang Wu, Hai-Qiang Zhang, et al.
Cancer Letters (2023) Vol. 568, pp. 216278-216278
Open Access | Times Cited: 7
Next-generation analytical platforms for antioxidant capacity assessment: The urge for realistic and physiologically relevant methods
Daniel Granato
Biomedicine & Pharmacotherapy (2023) Vol. 165, pp. 115155-115155
Open Access | Times Cited: 7
Eμ-TCL1xMyc: A Novel Mouse Model for Concurrent CLL and B-Cell Lymphoma
Fabienne Lucas, Kerry A. Rogers, Bonnie K. Harrington, et al.
Clinical Cancer Research (2019) Vol. 25, Iss. 20, pp. 6260-6273
Open Access | Times Cited: 21
Xenograft and cell culture models of Sézary syndrome reveal cell of origin diversity and subclonal heterogeneity
Sandrine Poglio, Martina Prochazkova‐Carlotti, Floriane Cherrier, et al.
Leukemia (2020) Vol. 35, Iss. 6, pp. 1696-1709
Open Access | Times Cited: 20
Petiveria alliacea Reduces Tumor Burden and Metastasis and Regulates the Peripheral Immune Response in a Murine Myeloid Leukemia Model
Natalia Murillo, Paola Lasso, Claudia Urueña, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 16, pp. 12972-12972
Open Access | Times Cited: 6
Development of Bexarotene Analogs for Treating Cutaneous T-Cell Lymphomas
Ankedo Warda, Lech J. P. Staniszewski, Zhela Sabir, et al.
Cells (2023) Vol. 12, Iss. 21, pp. 2575-2575
Open Access | Times Cited: 6
Dissecting the Genetic and Non-Genetic Heterogeneity of Acute Myeloid Leukemia Using Next-Generation Sequencing and In Vivo Models
Rhea Desai, Niloofar Zandvakili, Stefan K. Bohlander
Cancers (2022) Vol. 14, Iss. 9, pp. 2182-2182
Open Access | Times Cited: 10
Page 1 - Next Page

Scroll to top